Advance in DNA Methylation Research of Autism Spectrum Disorders
自闭症谱系障碍DNA甲基化研究进展

参考文献 References

[1] Liu DB, Wang ZY. Identification and Validation Novel Risk Genes for Autism Spectrum Disorder – A Meta-Analysis.Journal of Psychiatry and Brain Science,2017 1 (1) : 117-127.

[2] Numata S, Ye T, Hyde TM, Guitart-Navarro X, Tao R, Wininger M, Colantuoni C, Weinberger DR, Kleinman JE, Lipska BK. DNA methylation signatures in development and aging of the human prefrontal cortex. Am J Hum Genet,2012 90 (2) : 260-272.

[3] Horsthemke B, Wagstaff J. Mechanisms of imprinting of the Prader-Willi/Angelman region.Am J Med Genet A,2008 146A (16) : 2041-2052.

[4] Tatton-Brown K, Seal S, Ruark E, Harmer J, Ramsay E, Del Vecchio Duarte S, Zachariou A, Hanks S, O'Brien E, Aksglaede L, Baralle D, Dabir T, Gener B, Goudie D, Homfray T, Kumar A, Pilz DT, Selicorni A, Temple IK, Van Maldergem L, Yachelevich N; Childhood Overgrowth Consortium, van Montfort R, Rahman N. Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability.Nat Genet,2014 46 (4) : 385-388.

[5] Ramocki MB, Tavyev YJ, Peters SU. The MECP2 duplication syndrome. Am J Med Genet A,2010 152A (5) : 1079-1088.

[6] Zhu L, Wang X, Li XL, Towers A, Cao X, Wang P, Bowman R, Yang H, Goldstein J, Li YJ, Jiang YH. Epigenetic dysregulation of SHANK3 in brain tissues from individuals with autism spectrum disorders.Hum Mol Genet,2014 23 (6) : 1563-1578.

[7] Nagarajan RP, Hogart AR, Gwye Y, Martin MR, LaSalle JM. Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation.Epigenetics,2006 1 (4) : e1-11.

[8] Zhubi A, Chen Y, Dong E, Cook EH, Guidotti A, Grayson DR. Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (自闭症谱系障碍) cerebellum.Transl Psychiat,2014 4 : e349.

[9] Nguyen A, Rauch TA, Pfeifer GP, Hu VW. Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain.FASEB J,2010 24 (8) : 3036-3051.

[10] Wong CC, Meaburn EL, Ronald A, Price TS, Jeffries AR, Schalkwyk LC, Plomin R, Mill J. Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits.Mol Psychiat,2014 19 (4) : 495-503.

[11] Ladd-Acosta C, Hansen KD, Briem E, Fallin MD, Kaufmann WE, Feinberg AP. Common DNA methylation alterations in multiple brain regions in autism.Mol Psychiat,2014 19 (8) : 862-871.

[12] Nardone S, Sams DS, Reuveni E, Getselter D, Oron O, Karpuj M, Elliott E. DNA methylation analysis of the autistic brain reveals multiple dysregulated biological pathways.Transl Psychiat,2014 4 : e433.

[13] Berko ER, Suzuki M, Beren F, Lemetre C, Alaimo CM, Calder RB, Ballaban-Gil K, Gounder B, Kampf K, Kirschen J, Maqbool SB, Momin Z, Reynolds DM, Russo N, Shulman L, Stasiek E, Tozour J, Valicenti-McDermott M, Wang S, Abrahams BS, Hargitai J, Inbar D, Zhang Z, Buxbaum JD, Molholm S, Foxe JJ, Marion RW, Auton A, Greally JM. osaic epigenetic dysregulation of ectodermal cells in autism spectrum disorder.PLoS Genet,2014 10 (5) : e1004402.

[14] Wang Y, Fang Y, Zhang F, Xu M, Zhang J, Yan J, Ju W, Brown WT, Zhong N. Hypermethylation of the enolase gene (ENO2) in autism.Eur J Pediatr,2014 173 (9) : 1233-1244.

[15] Mikeska T, Craig JM. DNA methylation biomarkers: cancer and beyond.Genes (Basel),2014 5 (3) : 821-864.